# Atara Biotherapeutics, Inc.: Form 8-K, filed Sep 4, 2025

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2025-09-04
- Accepted by EDGAR: Sep 3, 2025, 18:05 ET
- Period: 2025-09-02
- Accession: 0000950170-25-112898
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000095017025112898/atra-20250902.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000095017025112898/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000095017025112898/atra-20250902.htm

Filed Sep 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-112898. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.